Osaic Holdings
HOWL icon

Osaic Holdings’s Werewolf Therapeutics HOWL Stock Holding History

Osaic Holdings’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.16K Hold
8,625
– – ﹤0.01% 6487
2025
Q4 		$5.43K Sell
8,625
-1,000
-10% -$1.22K ﹤0.01% 6666
2025
Q3 		$13.3K Hold
9,625
– – ﹤0.01% 6190
2025
Q2 		$10.5K Hold
9,625
– – ﹤0.01% 6119
2025
Q1 		$9.34K Buy
9,625
+1,050
+12% +$1.38K ﹤0.01% 5822
2024
Q4 		$12.7K Buy
+8,575
New +$17.5K ﹤0.01% 5631

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings's HOWL Position: Q1 2026 in Review

Osaic Holdings held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 8,625 shares worth $7.16K. The position accounts for ﹤0.01% of the portfolio, ranked #6487.

Osaic Holdings first reported a position in HOWL in Q4 2024 and has held it in 6 quarters since. The position peaked at $13.3K in Q3 2025. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Osaic Holdings held 8,625 shares of Werewolf Therapeutics worth $7.16K as of Q1 2026.
  • Osaic Holdings left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6487 holding.
  • Osaic Holdings first reported a position in Werewolf Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Osaic Holdings's Werewolf Therapeutics position peaked at $13.3K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.